I Background
-Approximately 25-35% of older adults complain of excessive daytime sleepiness. -Sleep apnea, a possible cause of daytime sleepiness, affects 5-15% of older adults -Despite evidence to show increased risk of adverse cardiovascular outcomes, no research to date has shown increased mortality from sleep apnea in older adults. II Hypothesis of the study: Sleep disordered breathing, in the presence of symptoms such as excessive daytime sleepiness, is associated with an increased risk of mortality
III Methods review
• Population chosen: Adults >65 years of age with cases having complaints of excessive daytime sleepiness (n=146) and controls having no excessive daytime sleepiness (n=143). Patients who did not clearly meet either criteria were excluded.
• Intervention: none. Longitudinal study • Outcome chosen: Mortality as determined from the Social Security Death Index • Statistics: Survival analysis using Cox proportional hazards models to control for possible covariates
IV Results
• Average follow-up was 13.8 years.
• Excessive daytime sleepiness was associated with an unadjusted mortality hazard ratio of 1.5 (95% CI 1.1-2.0).
• The adjusted mortality hazard ratio for study participants with both EDS and SDB (apnea-hypopnea index ≥ 20 events/h) was 2.3, 95% CI: 1.5-3.6 • The mortality risk was most prominent when sleep disordered breathing was defined as an apneahypopnea index >20 events/hr. • Other relevant covariates were sleep duration > 8.5 h, self-reported angina, male gender, African American race, and age • Sleep disordered breathing without excessive daytime sleepiness, and excessive daytime sleepiness without sleep disordered breathing, were not associated with an increased mortality risk V Authors' conclusions: Sleep disordered breathing, in the absence of excessive daytime sleepiness, may not increase the risk of mortality in older adults. VI Reviewer's Critique -Potential element of survivorship bias that could lead to under-estimation of the hazard ratio -Study risk factors (sleep disordered breathing, excessive daytime sleepiness) were not re-assessed during the study period.
VII Summary for practice implications -Only patients with significant symptoms, such as excessive daytime sleepiness, or persistent insomnia, may benefit from sleep apnea evaluation and treatment
